Background— Patients with systolic heart failure (HF) who develop secondary pulmonary
hypertension (PH) have reduced exercise capacity and increased mortality compared with HF …

Background Some patients with COVID-19 who have recovered from the acute infection
after experiencing only mild symptoms continue to exhibit persistent exertional limitation that …

Exercise provides numerous salutary effects, but our understanding of how these occur is
limited. To gain a clearer picture of exercise-induced metabolic responses, we have …

Background— Heart failure (HF) is frequently associated with dysregulation of nitric oxide–mediated
pulmonary vascular tone. Sildenafil, a type 5 phosphodiesterase inhibitor, lowers …

Background— The clinical relevance of exercise-induced pulmonary arterial hypertension (PAH)
is uncertain, and its existence has never been well studied by direct measurements of …

Postural orthostatic tachycardia syndrome (POTS) is a chronic and often disabling disorder
characterized by orthostatic intolerance with excessive heart rate increase without …

Background— Elevated resting pulmonary arterial pressure (PAP) in patients with left
ventricular systolic dysfunction (LVSD) purports a poor prognosis. However, PAP response …

Mitochondrial dysfunction may contribute to the development of insulin resistance and type
2 diabetes. Nucleoside reverse transcriptase inhibitors (NRTIs), specifically stavudine, are …

Profound and debilitating fatigue is the most common complaint reported among individuals
with autoimmune disease, such as systemic lupus erythematosus, multiple sclerosis, type 1 …

Background— Ventilatory efficiency, right ventricular (RV) function, and secondary pulmonary
hypertension are each prognostic indicators in patients with heart failure due to left …